Literature DB >> 18085529

Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes.

Jingxia Li1, Dongyun Zhang, Gary D Stoner, Chuanshu Huang.   

Abstract

The chemopreventive properties of edible berries have been demonstrated both in vitro and in vivo, however, the specific molecular mechanisms underlying their anti-cancer effects are largely unknown. Our previous studies have shown that a methanol extract fraction of freeze-dried black raspberries inhibits benzoapyrene (BaP)-induced transformation of Syrian hamster embryo cells. This fraction also blocks activation of activator protein-1 (AP-1) and nuclear factor kappaB (NF-kappaB) induced by benzoapyrene diol-epoxide (BaPDE) in mouse epidermal JB6 Cl 41 cells. To determine if different berry types exhibit specific mechanisms for their anti-cancer effects, we compared the effects of extract fractions from both black raspberries and strawberries on BaPDE-induced activation of various signaling pathways in Cl 41 cells. Black raspberry fractions inhibited the activation of AP-1, NF-kappaB, and nuclear factor of activated T cells (NFAT) by BaPDE as well as their upstream PI-3K/Akt-p70(S6K) and mitogen-activated protein kinase pathways. In contrast, strawberry fractions inhibited NFAT activation, but did not inhibit the activation of AP-1, NF-kappaB or the PI-3K/Akt-p70(S6K) and mitogen-activated protein kinase pathways. Consistent with the effects on NFAT activation, tumor necrosis factor-alpha (TNF-alpha) induction by BaPDE was blocked by extract fractions of both black raspberries and strawberries, whereas vascular endothelial growth factor (VEGF) expression, which depends on AP-1 activation, was suppressed by black raspberry fractions but not strawberry fractions. These results suggest that black raspberry and strawberry components may target different signaling pathways in exerting their anti-carcinogenic effects. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085529      PMCID: PMC3758121          DOI: 10.1002/mc.20377

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  38 in total

Review 1.  Cellular function of p70S6K: a role in regulating cell motility.

Authors:  L A Berven; M F Crouch
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

2.  Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway.

Authors:  Chuanshu Huang; Jingxia Li; Lun Song; Dongyun Zhang; Qiangsong Tong; Min Ding; Linda Bowman; Robeena Aziz; Gary D Stoner
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 3.  Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.

Authors:  Yulong L Chen; Ping-Y Law; Horace H Loh
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-11

4.  Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.

Authors:  Caren C Bancroft; Zhong Chen; Jason Yeh; John B Sunwoo; Ning T Yeh; Sadhana Jackson; Chad Jackson; Carter Van Waes
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

5.  Inhibition of cellular transformation by berry extracts.

Authors:  H Xue; R M Aziz; N Sun; J M Cassady; L M Kamendulis; Y Xu; G D Stoner; J E Klaunig
Journal:  Carcinogenesis       Date:  2001-02       Impact factor: 4.944

6.  Antimutagenic activity of berry extracts.

Authors:  S Hope Smith; Patricia L Tate; George Huang; James B Magee; Kumudini M Meepagala; David E Wedge; Lyndon L Larcom
Journal:  J Med Food       Date:  2004       Impact factor: 2.786

7.  Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.

Authors:  K L Tober; R E Cannon; J W Spalding; T M Oberyszyn; M L Parrett; A I Rackoff; A S Oberyszyn; R W Tennant; F M Robertson
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

8.  Anticarcinogenic Activity of Strawberry, Blueberry, and Raspberry Extracts to Breast and Cervical Cancer Cells.

Authors:  David E. Wedge; Kumudini M. Meepagala; James B. Magee; S. Hope Smith; George Huang; Lyndon L. Larcom
Journal:  J Med Food       Date:  2001       Impact factor: 2.786

Review 9.  Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

Authors:  Matthew R Young; Hsin-Sheng Yang; Nancy H Colburn
Journal:  Trends Mol Med       Date:  2003-01       Impact factor: 11.951

Review 10.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Authors:  M A Lawlor; D R Alessi
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  7 in total

1.  Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis.

Authors:  David C Montrose; Nicole A Horelik; James P Madigan; Gary D Stoner; Li-Shu Wang; Richard S Bruno; Hea Jin Park; Charles Giardina; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2010-11-23       Impact factor: 4.944

Review 2.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

3.  Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.

Authors:  Lynn S Adams; Sheryl Phung; Natalie Yee; Navindra P Seeram; Liya Li; Shiuan Chen
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 4.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

5.  Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression.

Authors:  Wei Zhang; Jo-Hsin Chen; Irene Aguilera-Barrantes; Chung-Wai Shiau; Xiugui Sheng; Li-Shu Wang; Gary D Stoner; Yi-Wen Huang
Journal:  Mol Nutr Food Res       Date:  2016-07-25       Impact factor: 5.914

6.  A rapid and sensitive LC-MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gel.

Authors:  Yonghua Ling; Chen Ren; Susan R Mallery; Carlos M Ugalde; Ping Pei; U V R Vijaya Saradhi; Gary D Stoner; Kenneth K Chan; Zhongfa Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-10-30       Impact factor: 3.205

7.  Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts.

Authors:  Cheng-Wei Lu; Ji-Long Hao; Lei Yao; Hai-Jun Li; Dan-Dan Zhou
Journal:  Int J Mol Med       Date:  2017-04-07       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.